Biotechnology companies are developing treatments for heart disease, muscle loss and kidney disease in dogs and cats, while researchers explore whether advances in animal longevity could inform future human therapies.
Biotechnology companies are developing treatments for heart disease, muscle loss and kidney disease in dogs and cats, while researchers explore whether advances in animal longevity could inform future human therapies.